PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested to fight back against rare liver disease
Disease control CompletedThis study tested whether adding a new drug called bezafibrate to an existing one (obeticholic acid) could better control Primary Biliary Changitis (PBC), a chronic liver disease. It involved 72 adults with PBC who were already on standard treatment. The main goal was to see if t…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New immune therapy tested for Tough-to-Treat liver disease
Disease control CompletedThis study tested an experimental drug called CNP-104 in adults with primary biliary cholangitis (PBC), a liver disease, who were not responding well to their current medications. The main goals were to see if the drug was safe and if it could help control the disease by reducing…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC